K

KGbio

24 employees

Kalbe Genexine Biologics is developing innovative biologic therapy for high unmet medical needs in largely underserved areas.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Life Science

Date founded

2016

Funding rounds raised

Total raised

$55M

from 1 investors over 1 rounds

K

KGbio raised $55M on January 26, 2021

Investors: General Atlantic

FAQ